PubMed Health⌕ Search

Biomedical subjects

B Farkas

Publications and source records attributed to B Farkas.

At least 37 records · Page 2Linked to original sources

Keratinocyte grafting: a new means of transplantation for full-thickness wounds.

Twenty adult individuals with chronic leg ulcers caused by venous insufficiency, and 5 patients with full-thickness burns were treated. Twenty of the patients (15 with leg ulcers and 5 with burns) were grafted with separated autologous keratinocytes. In these cases the cells were fixed to the wound bed by a fibrin net. Five other patients (with leg ulcers) were treated with fibrin without keratinocytes. In 16 of the 20 patients grafted with keratinocytes in a fibrin net, the defect healed completely in 14 to 21 days. On the other hand, the fibrin net without keratinocytes failed to significantly accelerate the process of reepithelialization. Our experience suggests that a rapid healing of full-thickness skin defects can be achieved through keratinocyte grafting.

Burns↗

Thermoluminescent dose measurements on-board Salyut type orbital stations.

A small, vibration- and shock-resistant thermoluminescent dosemeter /TLD/ system--named PILLE--was developed at the Health Physics Department of the Central Research Institute for Physics, Budapest, to measure the cosmic radiation dose on board orbital stations. The first on-board measurements with this system were performed /by B. Farkas, the Hungarian astronaut/, on the Salyut-6 space station in 1980. The same instrument was used by other crews in the following years. Doses measured at different sites in Salyut-6 are presented. The dose rates varied from 0.07 to 0.11 mGy.day-1. After the first cosmic measurements, the system was further developed. The minimum detectable dose of the new TLD system is 1 microGy, i.e. less by on order of magnitude than that of the former system. The self-irradiation dose rate of the TLD bulbs is also reduced--by more than one order of magnitude--to 10 nGy.h-1, by the use of potassium-free glass for the bulb envelope. This new type of PILLE TLD system is currently on-board Salyut-7. The dose rates /0.12-0.23 mGy.day-1/ measured in 1983 are presented in detail.

Evaluation Studies as Topic↗